Article: New Findings From Two Studies on Lybrel Presented at ACOG.

-Data Evaluate the Time to Return to Menses After Stopping Lybrel and Safety and Efficacy-

MADISON, N.J., May 8 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , announced today that two new scientific abstracts relating to the investigational, combination oral contraceptive Lybrel(TM) (90 micrograms levonorgestrel/20 micrograms ethinyl estradiol tablets) were presented this week at the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical Meeting in Washington, D.C.

The first scientific abstract reported on the return to menstruation after stopping the non-cyclic oral contraceptive (Lybrel). The study showed ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!